Thermo Fisher Scientific Inc company logo

# RNN 2nd Gen Model Thermo Fisher Scientific Inc Measuring & controlling devices, not elsewhere classified

Prediction models:
Subscribe >> Deal exit on
June 24, 2019
Deal entry on
June 24, 2019
7.17%Expected margin
72.73% successful of 11 deals
$ 285.26 Last close price
at 14-jun-2019


Model's trade recommendations No return for period yet

-12.33% Annual return

$83.91B Market Cap

β 1.14  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period
52wk return -17.41%
52wk Range
Sortino ratio -0.65
Sharpe ratio -0.62
Norm. RMSE 5.71%
Downside risk 17.65%
Volatility 0.00%
  • 0.68 (0.33%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.

Industry sector: Medical

Sector classification: Measuring & controlling devices, not elsewhere classified

Deep Learning based analysis and prediction model for Thermo Fisher Scientific Inc (TMO) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for TMO model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a regular basis.

Float 400M
P/E 21.09
Shares Outstanding 402M
% Held by Insiders 0.49%
% Held by Institutions 87.20%
EPS (last reported FY) $9.49
EPS (last reported Q) $2.50
EPS, estimated (last reported Q) $2.42
Total revenues $21 B
Net income $2 B